Mansour SE, Kiernan DF, Roth DB, Eichenbaum D, et al. Two-year interim safety results of the 0.2 microg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study. Br J Ophthalmol 2020 May 27. pii: bjophthalmol-2020-315984.
PMID: 32461262